Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Lidak Pharm. [LDAKA] -- Ignore unavailable to you. Want to Upgrade?

To: luis a. garcia who wrote (736)	12/23/1997 12:08:00 PM
From: John Zwiener	Read Replies (1) \| Respond to of 1115

Luis, just keep following biotechs a few more years and you will be a purist too. Let's just say I have talked to the people at Lidak for 2 years now on a regular basis and I did not once catch them trying to exaggerate something. No misrepresentations that I could detect, and believe me, I tried to find them. My initial reaction to the press releases was because this was the kind of stuff I see all the time in biotech, not clear, and bait and switch. But, if you take the press release at it's word..................... Let's do a calculation. Most of the placebo group was 8-10 days,,,Let's say 51% at 8 days We will arbitrarily say the other 49% was 4.1 days Average this and you get 6 days for the placebo group, in the worst case. Meanwhile, we know that Lidakol is 4.1 days, or 2 days better than the placebo minimum. That makes Lidakol the best drug by a day, minimum. And up to 3 to 4 to 5 days better under the best case. Maybe, lidak was not being evasive, I just had to figure it out. Does anyone know if the CEO likes riddles? Anyway, I need to check and see if my calculations are reasonable. By the way, my comment about Lidak dropping on news is because biotechs love to fall on positive news. About 90% of the time as far as I can tell.